Anti-Obesity Medications: Working With Your Biology, Not Against It

If you have been struggling with your weight and are looking for an effective medical solution that does not involve surgery — or if you are looking for additional support alongside your bariatric surgery journey — GLP-1 weight loss medications may be exactly what you need. These medications represent one of the most exciting advances in obesity medicine in decades, and I am genuinely enthusiastic about offering them as part of our comprehensive weight management program. Whether you are considering medication as your primary treatment or as part of a broader plan that includes surgery, our team is here to help you find the right path forward — and it all starts with a conversation.

GLP-1 stands for Glucagon-Like Peptide-1 — a hormone that your body naturally produces in the gut after eating. This hormone plays a powerful role in regulating appetite, blood sugar, and metabolism. GLP-1 receptor agonists are medications that mimic this natural hormone — amplifying its effects in ways that produce meaningful and clinically significant weight loss.

Here is what these medications do in simple terms:

• Reduce hunger — by acting on appetite centers in the brain, GLP-1 medications significantly reduce how hungry you feel throughout the day
• Increase fullness — they slow the rate at which food leaves the stomach, meaning you feel satisfied with smaller portions for longer periods of time
• Improve blood sugar control — they stimulate insulin release when blood sugar is elevated and reduce the liver's overproduction of glucose — making them particularly powerful for patients with type 2 diabetes or prediabetes
• Reduce food cravings — many patients report that cravings for high-sugar and high-fat foods decrease significantly on these medications — making healthy eating feel much more manageable
• Produce cardiovascular benefits — emerging research shows that GLP-1 medications reduce the risk of heart attack, stroke, and cardiovascular death — benefits that go far beyond weight loss alone

Several GLP-1 and dual-action medications are currently available, and new options continue to emerge. The most commonly prescribed include:

Semaglutide (Wegovy) — FDA Approved for Weight Loss

• Currently one of the most widely used and extensively studied weight loss medications available
• Administered as a once-weekly injection under the skin
• Clinical trials — the landmark STEP trials — showed average weight loss of approximately 15% of total body weight
• Also available as Ozempic — the same medication at different doses — approved specifically for type 2 diabetes management
• Has demonstrated significant cardiovascular benefits in large clinical trials — reducing the risk of heart attack and stroke in high-risk patients

Tirzepatide (Zepbound) — FDA Approved for Weight Loss

• A dual-action medication that targets both GLP-1 and GIP receptors — making it even more powerful than semaglutide alone
• Also administered as a once-weekly injection
• The SURMOUNT trials showed average weight loss of up to 20 to 22% of total body weight — the highest ever achieved by a weight loss medication in clinical trials
• Also available as Mounjaro — approved specifically for type 2 diabetes
• Produces exceptional improvements in blood sugar, blood pressure, cholesterol, and other metabolic conditions

Liraglutide (Saxenda) — FDA Approved for Weight Loss

• A daily injection — the original GLP-1 medication approved specifically for weight management
• Produces average weight loss of approximately 5 to 8% of total body weight
• Well established with a long safety record
• May be preferred in certain patients or as a stepping stone to higher-potency medications

Oral Semaglutide (Rybelsus)

• The only oral GLP-1 medication currently available — approved for type 2 diabetes management
• A convenient tablet taken once daily
• Produces less weight loss than injectable semaglutide but offers an appealing option for patients who prefer to avoid injections

Understanding how GLP-1 medications work helps explain why they are so effective — and why they represent such a meaningful advance beyond traditional weight loss approaches:

In the Brain

• GLP-1 receptors in the hypothalamus — the brain's appetite control center — are activated by these medications, producing a powerful and sustained reduction in hunger signals
• The reward pathways that drive food cravings — particularly for high-sugar and high-fat foods — are dampened, making it significantly easier to make healthier food choices without feeling deprived
• Many patients describe a fundamentally different relationship with food on these medications — the constant preoccupation with eating that characterizes obesity simply quiets down, often for the first time in their lives

In the Stomach

• GLP-1 medications slow gastric emptying — meaning food stays in the stomach longer after meals
• This produces a prolonged feeling of fullness and satisfaction that reduces overall caloric intake naturally — without the white-knuckle willpower that traditional dieting requires

In the Pancreas

• These medications stimulate the pancreas to produce insulin when blood sugar rises after eating — improving blood sugar control in a way that is directly tied to actual glucose levels
• They also suppress glucagon — a hormone that raises blood sugar — further improving metabolic control

In the Liver

• GLP-1 medications reduce the liver's overproduction of glucose — an important driver of elevated fasting blood sugar in patients with type 2 diabetes and insulin resistance
• They also reduce liver fat — producing meaningful improvements in fatty liver disease

In the Heart and Blood Vessels

• Beyond weight loss, GLP-1 medications have direct beneficial effects on the cardiovascular system — reducing inflammation, improving blood vessel function, and lowering blood pressure
• Large clinical trials have demonstrated that semaglutide reduces the risk of major cardiovascular events — heart attack, stroke, and cardiovascular death — by approximately 20% in high-risk patients

The results achievable with modern GLP-1 medications are the most impressive ever seen from a pharmaceutical weight loss treatment — and they represent a genuine breakthrough in obesity medicine:

Weight Loss

• Semaglutide (Wegovy) produces average weight loss of approximately 15% of total body weight — translating to 30 to 50 pounds for many patients
• Tirzepatide (Zepbound) produces average weight loss of up to 20 to 22% of total body weight — the highest ever achieved by any weight loss medication
• Individual results vary significantly — some patients lose more, some less — depending on starting weight, adherence, dietary habits, and individual biological response
• Weight loss is most rapid in the first 3 to 6 months and continues more gradually through the first year of treatment

Health Improvements The health benefits of GLP-1 medications extend far beyond the scale:

• Type 2 diabetes — blood sugar control improves dramatically — many patients reduce or eliminate diabetes medications
• Blood pressure — improves meaningfully in the majority of patients
• Cholesterol and triglycerides — improve significantly
• Sleep apnea — improves as weight comes off and airway fat decreases
• Joint pain — decreases as mechanical load on joints is reduced
• Fatty liver disease — improves as liver fat is reduced
• Cardiovascular risk — meaningfully reduced through both weight loss and the direct cardiovascular benefits of these medications
• Overall energy and quality of life — improve profoundly for most patients

I believe in complete honesty with every patient — and there are some important realities about GLP-1 medications that every patient deserves to understand fully before starting treatment:

These Medications Work Only While You Take Them

• GLP-1 medications manage obesity — they do not cure it
• Clinical trials consistently show that the majority of patients regain most of their lost weight within 1 to 2 years of stopping the medication
• This means that for most patients, GLP-1 medications are a long-term — potentially lifelong — commitment
• This is not a failure of the medication — it is a reflection of the chronic nature of obesity as a disease

Side Effects

• The most common side effects are gastrointestinal — nausea, vomiting, diarrhea, and constipation — particularly during the dose escalation phase in the first weeks to months of treatment
• These side effects are temporary for most patients and improve significantly as the body adjusts to the medication
• Starting at a low dose and gradually increasing — as is standard protocol — minimizes side effects and improves tolerability
• A small proportion of patients experience side effects severe enough to require dose reduction or discontinuation — something we manage carefully and supportively

Cost and Access

• GLP-1 medications are expensive — and insurance coverage varies significantly
• Our team will work with you to navigate insurance coverage, prior authorization requirements, and manufacturer patient assistance programs to maximize your access to these medications
• We also discuss realistic long-term cost considerations as part of our comprehensive medication consultation

Plateau

• Most patients experience a plateau in weight loss — typically after 12 to 18 months — where the medication's effect on weight stabilizes
• For patients who plateau well short of their health goals — particularly those with very high starting BMIs — combining medication with bariatric surgery may produce significantly better long-term results than medication alone

One of the most exciting developments in obesity medicine today is the recognition that GLP-1 medications and bariatric surgery are not competing options — they are powerful complements that can work together to produce outcomes neither approach could achieve alone.

We use GLP-1 medications strategically as part of our comprehensive bariatric program in several important ways:

Before Bariatric Surgery

• GLP-1 medications can be used to produce meaningful preoperative weight loss — reducing surgical risk, shrinking the liver to make surgery technically easier and safer, and demonstrating the patient's ability to commit to a medical weight loss program
• Preoperative weight loss of even 5 to 10% of body weight can meaningfully reduce anesthetic risk, operative time, and complication rates

After Bariatric Surgery

• For patients who experience weight regain after surgery — or who do not achieve their target weight loss — adding GLP-1 medications can produce meaningful additional weight loss and metabolic improvement
• The combination of surgical anatomy changes and medication produces synergistic effects — with many patients achieving their best-ever weight loss results through this combined approach

As an Alternative to Surgery

• For patients who do not meet surgical criteria, prefer to avoid surgery, or want to try a less invasive option first — GLP-1 medications offer meaningful weight loss and health improvement
• For patients who achieve adequate results with medication alone, surgery may not be necessary

For Weight Maintenance After Surgery

• Some patients use low-dose GLP-1 medications as a long-term tool for weight maintenance after bariatric surgery — helping sustain the results of surgery over the long term

GLP-1 medications may be an excellent option for a wide range of patients, including:

• Patients with a BMI of 27 or higher with at least one obesity-related health condition — or a BMI of 30 or higher regardless of other conditions — who meet FDA criteria for weight loss medication
• Patients with type 2 diabetes or prediabetes — who benefit from both the weight loss and the direct blood sugar improvements these medications produce
• Patients who prefer to start with a non-surgical option before considering bariatric surgery
• Patients who do not meet surgical criteria but want meaningful medical support for weight loss
• Patients after bariatric surgery who are experiencing weight recurrence or want to maximize their results
• Patients with cardiovascular disease — who benefit from both the weight loss and the documented cardiovascular protective effects of these medications
• Patients preparing for surgery — who want to reduce surgical risk through preoperative weight loss

If you are interested in GLP-1 medications — whether as your primary treatment or as part of a broader weight management plan — a consultation with our team is the perfect first step. Here is what to expect:

A Comprehensive Medical Evaluation We begin with a thorough review of your complete medical history, current medications, weight history, and health conditions — to determine which medication is most appropriate for you and to identify any contraindications or precautions.

A Personalized Medication Plan Not all GLP-1 medications are the same — and the right choice depends on your individual health profile, goals, insurance coverage, and preferences. We will recommend the most appropriate medication and dose escalation schedule for your specific situation — and we will be with you every step of the way as you adjust to the medication.

Dietary and Lifestyle Support GLP-1 medications work best when combined with healthy eating habits and regular physical activity. Our registered dietitian will work with you to develop a nutrition plan that maximizes your results on medication — and that builds the dietary foundation for long-term success whether or not you ultimately proceed to surgery.

Ongoing Monitoring and Support We monitor your response to medication closely — tracking weight loss, health improvements, side effects, and nutritional status — and adjust your treatment plan as needed. Our goal is to optimize your results while keeping you safe, comfortable, and well supported throughout your treatment.

An Honest Discussion of All Options Our consultation is not just about medications — it is about finding the right comprehensive treatment plan for your individual situation. We will discuss all available options — including medications, surgical procedures, endoscopic options, and combination approaches — so you can make the most informed and empowered decision possible about your health.

At the heart of our approach to GLP-1 medications is a simple but powerful belief: obesity is a chronic disease that deserves the same serious, evidence-based medical treatment as any other chronic condition. We do not prescribe a medication and send you home. We partner with you — providing the medical management, dietary support, behavioral guidance, and ongoing monitoring that give you the best possible chance of achieving and maintaining meaningful, lasting results.

Whether GLP-1 medications are the right primary treatment for you, a complement to surgery, or a bridge to a more definitive solution — our team has the expertise, the compassion, and the commitment to walk this journey with you every step of the way.

The bottom line: GLP-1 weight loss medications are one of the most exciting and effective advances in obesity medicine in a generation — and they are available to you right now, through our comprehensive weight management program. Whether you are looking for a non-surgical solution, preparing for surgery, managing weight after a previous procedure, or simply wanting to explore all your options — we are here to help. That conversation starts with a single consultation — and I genuinely look forward to having it with you.